Monsanto Announces $400 Million St. Louis Expansion Plan At Chesterfield Village Research Center

   Monsanto Announces $400 Million St. Louis Expansion Plan At Chesterfield
                           Village Research Center

PR Newswire

ST. LOUIS, April 23, 2013

ST. LOUIS, April 23, 2013 /PRNewswire/ --Monsanto Company today announced
plans to bring together its St. Louis-based industry-leading research and
development team on one campus when it completes a more than $400 million
expansion at its Chesterfield Village Research Center. The company plans to
begin work this summer and expects to add 675 jobs across St. Louis County
over the next three years.

Monsanto plans to add 36 new greenhouses, additional offices and laboratory
space as well as additional plant growth chambers to facilitate development of
its seed and trait pipeline. Greenhouses and plant growth chambers, which can
be programmed to represent any climate around the world, are a critical
component of Monsanto's research work as they offer Monsanto scientists an
opportunity to observe and select only the best performing seeds for in-ground

"Our Chesterfield Village Research Center is already a world-class facility,
and with our planned new investment, will truly be a home worthy of what I
believe is the most innovative team in agriculture," said Robb Fraley, Ph.D.,
Monsanto's chief technology officer. "Monsanto has pledged to help those in
agriculture find new ways to produce more while using less of our globe's

Monsanto's proposed expansion will enable greater collaboration between
researchers, as they work to develop new systems of technologies to make
agriculture more productive and more sustainable.

Monsanto currently has approximately 1,000 employees at its Chesterfield site,
which could have the capacity to house 2,000 local technology employees once
the project is complete. Today, the site comprises 1.5 million-square-feet and
includes approximately 250 laboratories, 122 plant growth chambers and two
acres of greenhouses. In addition to the new office and research space, the
company plans to add a new cafeteria for employees, a conference center and a
parking structure. The expansion is being made possible with the support of
the State of Missouri and St. Louis County.

"In Missouri, we take great pride in our state's status as a leader in the
biotechnology industry, and Monsanto's $400 million expansion in St. Louis
will accelerate our state's continued growth in this area," Missouri Gov. Jay
Nixon said. "One of the fastest-growing sectors of Missouri's economy is in
science and technology, and I remain committed to embracing these industries
to transform our economy and create next-generation jobs. Monsanto's major
investment in the state of Missouri, which will create hundreds of high-tech,
high-paying jobs while also boosting our construction industry, further
establishes the Show-Me State as a biotech powerhouse."

Monsanto's commercial and corporate teams will continue to occupy the
company's Creve Coeur campus, which also currently houses lab spaces. Once
employees are transferred to Chesterfield, those lab spaces may be converted
to other uses, Fraley said. Construction is expected to be completed in 2017,
and teams will begin moving to the Chesterfield site in phases beginning at
that time.

The new construction will be LEED certified.

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions
and agricultural products that improve farm productivity and food quality.
Monsanto remains focused on enabling both small-holder and large-scale farmers
to produce more from their land while conserving more of our world's natural
resources such as water and energy. To learn more about our business and our
commitments, please visit: Follow our business on Twitter^®
at, on the company blog, Beyond the Rows at, or subscribe to our News Release RSS Feed.

Cautionary Statements Regarding Forward-Looking Information:

Certain statements contained in this release are "forward-looking statements,"
such as statements concerning the company's anticipated financial results,
current and future product performance, regulatory approvals, business and
financial plans and other non-historical facts. These statements are based on
current expectations and currently available information. However, since these
statements are based on factors that involve risks and uncertainties, the
company's actual performance and results may differ materially from those
described or implied by such forward-looking statements. Factors that could
cause or contribute to such differences include, among others: continued
competition in seeds, traits and agricultural chemicals; the company's
exposure to various contingencies, including those related to intellectual
property protection, regulatory compliance and the speed with which approvals
are received, and public acceptance of biotechnology products; the success of
the company's research and development activities; the outcomes of major
lawsuits and the previously-announced SEC investigation; developments related
to foreign currencies and economies; successful operation of recent
acquisitions; fluctuations in commodity prices; compliance with regulations
affecting our manufacturing; the accuracy of the company's estimates related
to distribution inventory levels; the company's ability to fund its short-term
financing needs and to obtain payment for the products that it sells; the
effect of weather conditions, natural disasters and accidents on the
agriculture business or the company's facilities; and other risks and factors
detailed in the company's most recent Form 10-K Report to the SEC. Undue
reliance should not be placed on these forward-looking statements, which are
current only as of the date of this release. The company disclaims any current
intention or obligation to update any forward-looking statements or any of the
factors that may affect actual results.

Contact Charla Lord (314-694-2993)

SOURCE Monsanto Company

Press spacebar to pause and continue. Press esc to stop.